- idUS
- Listar por autor
Listar por autor "Mandala, Mario"
Mostrando ítems 1-2 de 2
-
Artículo
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Mandala, Mario; Larkin, James R.; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cruz Merino, Luis de la; Weber, Jeffrey; Lobo, Maurice (BMJ Publishing Group, 2021-08-21)Background Several therapeutic options are now available in the adjuvant melanoma setting, mandating an understanding ...
-
Artículo
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma
Dreno, Brigitte; Ascierto, Paolo A.; Atkinson, Victoria; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Cruz Merino, Luis de la; Ribas, Antoni (Nature publishing group, 2018)Background: In the coBRIM study, cobimetinib plus vemurafenib (C þ V) significantly improved survival outcomes vs placebo ...